Comparable to other biopharma, but nothing that stands out
Revisión
See no way to improve, company likely not to succeed
Revisión
Toxic, culture of favoritism and not based on trust or respect
Revisión
Team does not work together well, all more concerned with impressing management, that more concerned about “optics” of a problem rather than solving a problem
Revisión
Do not feel I was offered a fair compensation package at first, felt like it was a “low ball offer” and turned them down at first, in retrospect I should have refused the second offer
Revisión